September 28, 2023
OCULUS, Inc. has announced a strategic partnership with LUVO to bring new specialty care devices to the U.S. optometry and ophthalmology market. This partnership serves to equip eye care practitioners with the best solutions in OCULUS diagnostics and LUVO patient treatment.
OCULUS is launching the LUVO LUCENT and DARWIN with 
Intense Pulse Light and Radio Frequency therapy, enabling eye care professionals to offer safe, effective, and comfortable treatments to their patients in their own offices.
The Intense Pulse Light (IPL) therapy offered through the LUCENT IPL and DARWIN multimodality workstation delivers energy at several different wavelengths to treat multiple conditions. This allows eye care practitioners to manage patients and provide treatment in their own practice, reducing the need to refer patients to external providers.
Eye care professionals can enjoy multiple IPL applications, several pulse modes, and advanced cooling technology while benefiting from the user-friendly interface that makes it easy to choose treatment parameters based on skin types.
The Thermal Radio Frequency (Refresh RF) handpiece included with the DARWIN workstation complements IPL therapy and enables eye care professionals to treat regardless of skin type. Using the Non-Pole Thermal Structure (NTTSTM ) technology, the DARWIN delivers focused and uniform thermal energy to heat the target area.
“Maintaining our dedication to specialty eye care, OCULUS had been searching for the ideal treatment partner to align with our premium diagnostic equipment. With LUVO’s superior quality, shared corporate values, and experience in the Canadian eye care market, we knew we had found our partner,” said TJ Flynn, Director of Business Development for OCULUS. “We look forward to introducing these devices to the market the way ECPs expect, with an emphasis on education and unparalleled customer support.”
OCULUS will be presenting the LUCENT and DARWIN to the U.S. ophthalmic market for the first time at Vision Expo West in Las Vegas and the American Academy of Ophthalmology in San Francisco.
